74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
P Palvella Therapeutics Inc
P
Closed
SectorHealthcare
112.37 -0.74
Overview
Share price change
24h
Min
110.16
Max
112.37
Income | -1.9M -11M |
|---|---|
Employees | 14 |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +91.1% upside |
Next Earnings | 30 Mar 2026 |
|---|
Market Cap | 1.6B |
|---|---|
Previous open | 113.11 |
Previous close | 112.37 |
News Sentiment
By Acuity
50%
50%
165 / 350 Healthcare
Palvella Therapeutics Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Palvella Therapeutics Inc Forecast
Price Target
By TipRanks
91.1% upside
12 Months Forecast
Average 217.68 USD 91.1%
High 267 USD
Low 76.43 USD
Based on 12 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
165 / 350 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Pre-tax profit
Sales
Interest expense on debt
Operating profit
$
Live chat